데이터를 보충하는 중입니다. 잠시 후 페이지를 새로 고치면 최신 내용을 볼 수 있습니다
69542-93-4CC(C)(C)C(=O)NCCCC(=O)OSRPNQDXRVRCTNK-UHFFFAOYSA-N69542-93-4DTXSID3046162CHEMBL1870796CHEBI:134834안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
개요Tonerg was launched in Italy for treatment of acute and post traumatic stress syndrome and "burnout" syndrome. It inhibits hypothalamic release of corticotropinreleasing factor (CRF) and effectively antagonizes the activation of CRF induced stress (neuroendocrine, autonomic and behavior responses). Tonerg is an atypical antidepressant because it does not involve the monoaminergic system and differs in effect from benzodiazepines (complete opposite effect of Diazepam). The entire molecule is responsible for activity. It is lipophilic, orally bioavailable, and has a halflife of 4-6 hr. Tonerg has a positive effect on sleep disorders by reducing insomnia, improving anxiety by 20% and depression by 23%.
현재 필터 조건에 해당하는 반응 기록이 없습니다.
불러오는 중…